BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26589963)

  • 1. Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.
    Nirmala N; Brachat A; Feist E; Blank N; Specker C; Witt M; Zernicke J; Martini A; Junge G
    Pediatr Rheumatol Online J; 2015 Nov; 13():50. PubMed ID: 26589963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.
    Feist E; Quartier P; Fautrel B; Schneider R; Sfriso P; Efthimiou P; Cantarini L; Lheritier K; Leon K; Karyekar CS; Speziale A
    Clin Exp Rheumatol; 2018; 36(4):668-675. PubMed ID: 29533755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.
    Li H; Abramova I; Chesoni S; Yao Q
    Clin Rheumatol; 2018 Aug; 37(8):2021-2026. PubMed ID: 29909561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
    Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
    Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses.
    Dunger-Baldauf C; Nakasato P; Noviello S; Whelan S; Bieth B
    Rheumatol Ther; 2022 Apr; 9(2):753-762. PubMed ID: 35044647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.
    Hoffmann MC; Cavalli G; Fadle N; Cantoni E; Regitz E; Fleser O; Klemm P; Zaks M; Stöger E; Campochiaro C; Tomelleri A; Baldissera E; Bittenbring JT; Zimmer V; Pfeifer J; Fischer Y; Preuss KD; Bewarder M; Thurner B; Fuehner S; Foell D; Dagna L; Kessel C; Thurner L
    J Clin Immunol; 2024 Jan; 44(2):45. PubMed ID: 38231276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canakinumab for the treatment of adult-onset Still's disease.
    Sfriso P; Bindoli S; Doria A; Feist E; Galozzi P
    Expert Rev Clin Immunol; 2020 Feb; 16(2):129-138. PubMed ID: 31957508
    [No Abstract]   [Full Text] [Related]  

  • 8. Adult-onset Still's disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?
    Mitrovic S; Hassold N; Kamissoko A; Rosine N; Mathian A; Mercy G; Pertuiset E; Nocturne G; Fautrel B; Koné-Paut I
    Rheumatology (Oxford); 2022 May; 61(6):2535-2547. PubMed ID: 34559214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.
    Kontzias A; Petryna O; Nakasato P; Efthimiou P
    Mediterr J Rheumatol; 2024 Mar; 35(Suppl 1):45-57. PubMed ID: 38756937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.
    Hur P; Yi E; Ionescu-Ittu R; Manceur AM; Lomax KG; Cammarota J; Xie J; Gautam R; Nakasato P; Sanghera N; Kim N; Grom AA
    Rheumatol Ther; 2022 Feb; 9(1):265-283. PubMed ID: 34874547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
    Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
    Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
    Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
    Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.
    Pay S; Türkçapar N; Kalyoncu M; Simşek I; Beyan E; Ertenli I; Oztürk MA; Düzgün N; Erdem H; Ozbalkan Z; Kiraz S; Kinikli G; Besbas N; Dinç A; Ateş A; Olmez U; Calgüneri M; Aydintuğ OT; Bakkaloğlu A; Turan M; Turgay M; Karaaslan Y; Topaloğlu R; Duman M; Ozen S;
    Clin Rheumatol; 2006 Sep; 25(5):639-44. PubMed ID: 16365690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
    Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
    Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review.
    Cota-Arce JM; Cota J; De León-Nava MA; Hernández-Cáceres A; Moncayo-Salazar LI; Valle-Alvarado F; Cordero-Moreno VL; Bonfil-Solis KL; Bichara-Figueroa JE; Hernández-Hernández J; Villela L
    Semin Arthritis Rheum; 2021 Dec; 51(6):1282-1290. PubMed ID: 34493394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity.
    Kudela H; Drynda S; Lux A; Horneff G; Kekow J
    BMC Rheumatol; 2019; 3():4. PubMed ID: 30886992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Park EH; Lee EY; Shin K; Kim HA
    Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Still's disease in children and adults].
    Hedrich CM; Günther C; Aringer M
    Hautarzt; 2017 Jun; 68(6):497-511. PubMed ID: 28451698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.